{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:26:00Z","timestamp":1740108360887,"version":"3.37.3"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Radiol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00247-019-04497-z","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T04:59:54Z","timestamp":1566449994000},"page":"142-145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hypothalamic hamartomas and inner ear diverticula with X-linked stapes gusher syndrome - new associations?"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9656-166X","authenticated-orcid":false,"given":"Emily A.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"\u00d6z\u00fctemiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley S.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy J.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Nascene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,22]]},"reference":[{"key":"4497_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2174\/1389202919666171218163046","volume":"19","author":"V Corvino","year":"2018","unstructured":"Corvino V, Apisa P, Malesci R et al (2018) X-linked sensorineural hearing loss: a literature review. Curr Genomics 19:327\u2013338","journal-title":"Curr Genomics"},{"key":"4497_CR2","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/acn3.300","volume":"3","author":"H Saitsu","year":"2016","unstructured":"Saitsu H, Sonoda M, Higashijima T et al (2016) Somatic mutations in GLI3 and OFD1 involved in sonic hedgehog signaling cause hypothalamic hamartoma. Ann Clin Transl Neurol 3:356\u2013365","journal-title":"Ann Clin Transl Neurol"},{"key":"4497_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12881-017-0484-6","volume":"18","author":"A Yang","year":"2017","unstructured":"Yang A, Kim J, Ki CS et al (2017) HDR syndrome with a novel mutation in GATA3 mimicking a congenital X-linked stapes gusher: a case report. BMC Med Genet 18:121","journal-title":"BMC Med Genet"},{"key":"4497_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12881-018-0630-9","volume":"19","author":"Y Su","year":"2018","unstructured":"Su Y, Gao X, Huang SS et al (2018) Clinical and molecular characterization of POU3F4 mutations in multiple DFNX2 Chinese families. BMC Med Genet 19:157\u2013167","journal-title":"BMC Med Genet"},{"key":"4497_CR5","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S1673-8527(09)60096-5","volume":"37","author":"J Li","year":"2010","unstructured":"Li J, Cheng J, Lu Y et al (2010) Identification of a novel mutation in POU3F4 for prenatal diagnosis in a Chinese family with X-linked nonsyndromic hearing loss. J Genet Genomics 37:787\u2013793","journal-title":"J Genet Genomics"},{"key":"4497_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166618","volume":"11","author":"A Pollak","year":"2016","unstructured":"Pollak A, Lechowicz U, K\u0119dra A et al (2016) Novel and de novo mutations extend association of POU3F4 with distinct clinical and radiological phenotype of hearing loss. PLoS One 11:e0166618","journal-title":"PLoS One"},{"key":"4497_CR7","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1002\/j.1460-2075.1992.tb05320.x","volume":"11","author":"JM Mathis","year":"1992","unstructured":"Mathis JM, Simmons DM, He X et al (1992) Brain 4: a novel mammalian POU domain transcription factor exhibiting restricted brain-specific expression. EMBO J 11:2551\u20132561x","journal-title":"EMBO J"},{"key":"4497_CR8","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1101\/gad.9.24.3122","volume":"9","author":"MD Schonemann","year":"1995","unstructured":"Schonemann MD, Ryan AK, McEvilly RJ et al (1995) Development and survival of the endocrine hypothalamus and posterior pituitary gland requires the neuronal POU domain factor Brn-2. Genes Dev 9:3122\u20133135","journal-title":"Genes Dev"}],"container-title":["Pediatric Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-019-04497-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00247-019-04497-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-019-04497-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T23:10:15Z","timestamp":1597965015000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00247-019-04497-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,22]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["4497"],"URL":"https:\/\/doi.org\/10.1007\/s00247-019-04497-z","relation":{},"ISSN":["0301-0449","1432-1998"],"issn-type":[{"type":"print","value":"0301-0449"},{"type":"electronic","value":"1432-1998"}],"subject":[],"published":{"date-parts":[[2019,8,22]]},"assertion":[{"value":"13 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Bradley Miller is a consultant for AbbVie, Ascendis, Ferring, Novo Nordisk, Pfizer, Sandoz, Soleno and Tolmar and has previously received support from Alexion, Ascendis, BioMarin, Endo Pharmaceuticals, Genentech, Genyme, Novo Nordisk, Opko, Sandoz, Sangamo, Shire, Tolmar and Versartis. David Nascene is a consultant for Biogen and World Care Clinical.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}